Gemini Sees Revenues in Fiscal Year Q4 | GenomeWeb

NEW YORK, May 14 – Gemini Genomics, a clinical genomics company based in Cambridge, UK, posted Monday fourth-quarter revenues of $1.5 million, compared with no revenues in the year ago quarter.

For the company’s 2000 fiscal year, which ended March 31, Gemini recorded revenue of $1.6 million, compared with $200,000 in the year ago period.

The company attributed the increase in revenue to two non-exclusive agreements it signed during the year with CuraGen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."